Abound Wealth Management’s Valero Energy VLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.01K Sell
15
-156
-91% -$38.4K ﹤0.01% 637
2026
Q1
$42.1K Buy
171
+131
+328% +$27K 0.01% 274
2025
Q4
$6.44K Buy
40
+4
+11% +$678 ﹤0.01% 611
2025
Q3
$6.18K Buy
36
+2
+6% +$298 ﹤0.01% 599
2025
Q2
$4.59K Hold
34
﹤0.01% 592
2025
Q1
$4.51K Sell
34
-7
-17% -$929 ﹤0.01% 561
2024
Q4
$5.03K Sell
41
-15
-27% -$2.01K ﹤0.01% 526
2024
Q3
$7.58K Sell
56
-5
-8% -$726 ﹤0.01% 466
2024
Q2
$9.59K Sell
61
-2
-3% -$323 ﹤0.01% 381
2024
Q1
$10.8K Sell
63
-6
-9% -$860 ﹤0.01% 355
2023
Q4
$9.01K Buy
69
+3
+5% +$382 ﹤0.01% 389
2023
Q3
$9.39K Buy
66
+5
+8% +$655 ﹤0.01% 338
2023
Q2
$7.18K Buy
61
+9
+17% +$1.05K ﹤0.01% 402
2023
Q1
$7.28K Buy
52
+9
+21% +$1.21K ﹤0.01% 332
2022
Q4
$5.47K Sell
43
-18
-30% -$2.26K ﹤0.01% 336
2022
Q3
$6.54K Buy
+61
New +$6.71K ﹤0.01% 330

Other funds holding VLO

Abound Wealth Management's VLO Position: Q2 2026 in Review

Abound Wealth Management reduced its Valero Energy (VLO) stake by 91% in Q2 2026, selling an estimated $38.4K and leaving 15 shares worth $4.01K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Abound Wealth Management first reported a position in VLO in Q3 2022 and has held it in 16 quarters since. The position peaked at $42.1K in Q1 2026. 1,970 funds tracked by Wall St. Rank hold VLO as of Q2 2026.

  • Abound Wealth Management held 15 shares of Valero Energy worth $4.01K as of Q2 2026.
  • Abound Wealth Management sold 156 Valero Energy shares in Q2 2026, an estimated $38.4K.
  • Valero Energy made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #637 holding.
  • Abound Wealth Management first reported a position in Valero Energy in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Valero Energy position peaked at $42.1K in Q1 2026.
  • 1,970 funds tracked by Wall St. Rank held Valero Energy as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.